Use of plasmapheresis and intravenous immunoglobulins in pregnant women with antiphospholipid syndrome
Our objective was to demonstrate the efficiency of therapy for antiphospholipid syndrome (APS) in pregnant women using plasmapheresis and intravenous immunoglobulins.92 women with diagnosed APS and 47 APS-free women with physiological pregnancy were under study. APS was diagnosed in accordance with...
Main Authors: | E. S. Orlova, S. V. Chepanov, M. S. Zainulina, S. A. Selkov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
2025-01-01
|
Series: | Медицинская иммунология |
Subjects: | |
Online Access: | https://www.mimmun.ru/mimmun/article/view/2893 |
Similar Items
-
USE OF INTRAVENOUS IMMUNOGLOBULIN WITHIN THE IVF/ICSI PROTOCOL IN WOMEN WITH INFERTILITY AND ANTIPHOSPHOLIPID ANTIBODIES
by: M. I. Krivonos, et al.
Published: (2017-12-01) -
Use of intravenous immunoglobulin in antiphospholipid antibody positive patients with high risk of miscarriage: a systematic review and meta-analysis
by: Xin Yuan, et al.
Published: (2024-10-01) -
IMMUNOREGULATORY EFFECTS OF INTRAVENOUS IMMUNOGLOBULINS
by: S. A. Sel'kov, et al.
Published: (2014-07-01) -
Effectiveness of high‐dose i.v. immunoglobulin therapy for pregnant women with aspirin–heparin‐resistant secondary antiphospholipid syndrome
by: Yoko Maesawa, et al.
Published: (2018-04-01) -
Correlation between indicators of hemostasis system activity and antiphospholipid antibodies levels in women with miscarriage
by: Elena N Kravchenko, et al.
Published: (2019-10-01)